These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 24375558)

  • 1. CD75: a B-cell marker which should not be forgotten in lymphocyte predominant Hodgkin lymphoma.
    Carbone A; Gloghini A
    Am J Hematol; 2014 Apr; 89(4):449. PubMed ID: 24375558
    [No Abstract]   [Full Text] [Related]  

  • 2. Modern management of lymphocyte-predominant Hodgkin lymphoma.
    Xing KH; Savage KJ
    Br J Haematol; 2013 May; 161(3):316-29. PubMed ID: 23398605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical and laboratory approach to the CD5/CD10 negative B-cell chronic lymphoproliferative leukemias.
    Hanson CA; Morice WG
    Am J Hematol; 2008 May; 83(5):347-8. PubMed ID: 18383327
    [No Abstract]   [Full Text] [Related]  

  • 4. The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma.
    Browne P; Petrosyan K; Hernandez A; Chan JA
    Am J Clin Pathol; 2003 Nov; 120(5):767-77. PubMed ID: 14608905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pitfalls and update in haematopathology. Case 7. Nodular lymphocyte predominant Hodgkin lymphoma].
    Moreau A
    Ann Pathol; 2012 Oct; 32(5):363-70. PubMed ID: 23141946
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic significance of PU.1 in follicular lymphoma.
    Torlakovic EE; Bilalovic N; Golouh R; Zidar A; Angel S
    J Pathol; 2006 Jul; 209(3):352-9. PubMed ID: 16639693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and classification of B-cell non-Hodgkin lymphomas. The role of multiparameter flow cytometry.
    Carulli G; Marini A
    Clin Ter; 2012; 163(1):47-57. PubMed ID: 22362234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 cases.
    Tzankov A; Zimpfer A; Pehrs AC; Lugli A; Went P; Maurer R; Pileri S; Dirnhofer S
    Mod Pathol; 2003 Nov; 16(11):1141-7. PubMed ID: 14614054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias.
    Goldaniga M; Ferrario A; Cortelazzo S; Guffanti A; Pavone E; Ambrosetti A; Marcheselli L; Rossi F; Luminari S; Rossi A; Cro L; Federico M; Lambertenghi Deliliers G; Baldini L
    Am J Hematol; 2008 May; 83(5):349-54. PubMed ID: 18186522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pitfalls and update in haematopathology. Case 4: limits of needle biopsies for assessment of lymphoid lesions].
    Molina T
    Ann Pathol; 2012 Oct; 32(5):346-50. PubMed ID: 23141943
    [No Abstract]   [Full Text] [Related]  

  • 11. Composite recurrent hodgkin lymphoma and diffuse large B-cell lymphoma: one clone, two faces.
    Huang Q; Wilczynski SP; Chang KL; Weiss LM
    Am J Clin Pathol; 2006 Aug; 126(2):222-9. PubMed ID: 16891197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvillous lymphomas are B-cell neoplasms that frequently express CD56.
    Hammer RD; Vnencak-Jones CL; Manning SS; Glick AD; Kinney MC
    Mod Pathol; 1998 Mar; 11(3):239-46. PubMed ID: 9521469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodular lymphocyte-predominant Hodgkin lymphoma presenting as fulminant hepatic failure in a pediatric patient: a case report with pathologic, immunophenotypic, and molecular findings.
    Woolf KM; Wei MC; Link MP; Arber DA; Warnke RA
    Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):196-201. PubMed ID: 18227720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular and serum levels of aldolase activity in B chronic lymphocytic leukemia.
    Musolino C; Alonci A; Allegra A; Di Cesare E; Orlando A; Grosso P; Buda G; Squadrito G
    Int J Hematol; 1992 Dec; 56(3):213-7. PubMed ID: 1477333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
    Miettinen M
    Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival.
    Muenst S; Hoeller S; Dirnhofer S; Tzankov A
    Hum Pathol; 2009 Dec; 40(12):1715-22. PubMed ID: 19695683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
    Zettl A; Rüdiger T; Marx A; Müller-Hermelink HK; Ott G
    Histopathology; 2005 Feb; 46(2):217-28. PubMed ID: 15693895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of octamer-binding transcription factors Oct2 and Oct1 and their coactivator BOB.1/OBF.1 in lymphomas.
    Sáez AI; Artiga MJ; Sánchez-Beato M; Sánchez-Verde L; García JF; Camacho FI; Franco R; Piris MA
    Mod Pathol; 2002 Mar; 15(3):211-20. PubMed ID: 11904338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic markers in non-Hodgkin's lymphoma.
    Freedman AS; Nadler LM
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transplant lymphoproliferative disorder with Hodgkin's lymphoma and large B-cell lymphoma differentiation.
    Novoa-Takara L; Dincer A; Kampalath B; Van Tuinen P; Hariharan S; Chang C
    Histopathology; 2005 Sep; 47(3):333-4. PubMed ID: 16115242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.